By analyzing the genetic alterations in diffuse low‐grade gliomas, Aoki et al. found that altered RB pathway genes including CDKN2A and CDK4 could be independent predictors of poor survival in IDH-mutant astrocytomas [9]. This evidence concerns the gene CDK4 and astrocytoma (excluding glioblastoma).